Sign in

Science Corp

@science.xyz
102 followers 2 following 213 posts

Building a brighter tomorrow enabled by neural engineering

PostsRepliesMedia
Science Corp @science.xyz · 03/10/2026
Today at EURETINA 2026, the latest PRIMA clinical trial data will be presented during the Industry Symposium “PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes.”
100
Science Corp @science.xyz · 03/10/2026
Heute werden bei der EURETINA 2026 die neuesten Daten aus der PRIMA-Studie im Industriesymposium „PRIMA Retinal Implant in Geographic Atrophy: Pivotal Trial Evidence and 36-Month Outcomes“ vorgestellt.
100
Science Corp @science.xyz · 02/10/2026
Mahi Muqit, MD, PhD, will present the 36-Month outcomes from the PRIMA clinical trial today at EURETINA 2026 in Vienna. See the full list of PRIMA sessions in the link in the comments.
120
Science Corp @science.xyz · 02/10/2026
Mahi Muqit, MD, PhD, stellt heute bei der EURETINA 2026 in Wien die Ergebnisse nach 36 Monaten aus der klinischen Studie zu PRIMA vor. Der Link zu allen PRIMA-Sessions steht im ersten Kommentar.
110
Science Corp @science.xyz · 01/10/2026
EURETINA 2026 begins today in Vienna. Frank Holz, MD, will deliver the keynote lecture "The Dark Side of the Moon: New Horizons in Dry AMD." See the full PRIMA program in the comments.
100
Science Corp @science.xyz · 30/09/2026
At EURETINA 2026 in Vienna this week, researchers and clinicians behind the PRIMA clinical program will present across nine sessions. See the full PRIMA program in the comments.
100
Science Corp @science.xyz · 30/09/2026
Diese Woche sind Forschende und klinisch tätige Ärzt:innen aus den klinischen Aktivitäten rund um PRIMA bei der EURETINA 2026 in Wien mit Beiträgen in neun Sessions vertreten. Der Link zum vollständigen PRIMA-Programm steht im ersten Kommentar.
101
Science Corp @science.xyz · 28/09/2026
Bei der DOG 2026 in Berlin stellte das PRIMA-Team diese Woche in neun Sessions aktuelle Forschungs- und klinische Entwicklungen vor. Danke an die DOG und alle Beteiligten. Mehr über PRIMA: Link in den Kommentaren.
100
Science Corp @science.xyz · 28/09/2026
This week at DOG 2026 in Berlin, researchers and clinicians behind the PRIMA clinical program shared the latest research and clinical developments across nine scientific sessions. Thank you to DOG and the physicians, researchers and broader ophthalmology community who joined us this week.
100
Science Corp @science.xyz · 26/09/2026
Bei der DOG 2026 in Berlin stellen Frank G. Holz, Armin Wolf und Boris Stanzel heute das PRIMA-Netzhautimplantat bei geografischer Atrophie vor. Eine Expertenrunde diskutiert Behandlung und Überweisungswege. Programm: Link in den Kommentaren.
100
Science Corp @science.xyz · 26/09/2026
Frank G. Holz, MD, Armin Wolf, MD, and Boris Stanzel, MD, PhD, will present “PRIMA Retinal Implant in Geographic Atrophy: From Pivotal Trial Data to the Clinic” today at DOG Deutsche Ophthalmologische Gesellschaft 2026 in Berlin.
100
Science Corp @science.xyz · 25/09/2026
Lars-Olof Hattenbach, MD, PhD, will deliver the keynote DOG Deutsche Ophthalmologische: “Vision Restoration with the PRIMA Implant: What’s Next?” highlighting results from the PRIMA clinical trial in Berlin. See the full list of PRIMA sessions at DOG 2026 in the link in the comments.
110
Science Corp @science.xyz · 25/09/2026
Lars-Olof Hattenbach spricht bei der DOG 2026 in Berlin über die Wiederherstellung des Sehvermögens mit dem PRIMA-Implantat. Klinische Studien zeigen: PRIMA kann bei geografischer Atrophie funktionales zentrales Sehen wiederherstellen. Programm: Link in den Kommentaren.
100
Science Corp @science.xyz · 24/09/2026
Blind Stargardt patient reads letter again in PRIMA by Science clinical trial. Stargardt disease destroys central vision. There is no treatment that brings it back. This clinical trial patient was diagnosed with Stargardt disease and became legally blind – he could no longer read or recognize faces
142
Science Corp @science.xyz · 24/09/2026
Deutsche Ophthalmologische Gesellschaft 2026 begins today in Berlin with four sessions focused on PRIMA. Today’s program includes:
100
Science Corp @science.xyz · 24/09/2026
DOG Deutsche Ophthalmologische Gesellschaft 2026 in Berlin: Heute stehen vier PRIMA-Sessions auf dem Programm. Themen sind Implantation, Netzhautbildgebung, iOCT und künstliches Sehen. Das vollständige Programm: Link in den Kommentaren.
000
Science Corp @science.xyz · 23/09/2026
Auf der DOG 2026 präsentieren Forschende und Ärzt:innen der PRIMA-Studie diese Woche in neun Sessions ihre Arbeit. Dazu gehören eine Keynote zur Wiederherstellung des Sehvermögens mit dem PRIMA-Implantat und ein Symposium zur geografischen Atrophie.
000
Science Corp @science.xyz · 21/09/2026
At DOG 2026 this week, researchers and clinicians behind the PRIMA clinical trial will present across nine sessions including a keynote on “Vision Restoration with the PRIMA Implant: What's Next?” and a symposium “PRIMA Retinal Implant in Geographic Atrophy: From Pivotal Trial Data to the Clinic.”
100
Science Corp @science.xyz · 15/09/2026
Our 2026 summer interns, in their own words and their own edit. We were lucky to have them!
160
Science Corp @science.xyz · 12/09/2026
Unser neuer Radiospot für PRIMA, unser Netzhautimplantat zur Behandlung der geografischen Atrophie infolge altersbedingter Makuladegeneration, wurde heute während der Bundesliga-Übertragung ausgestrahlt. Hier anhören:
020
Science Corp @science.xyz · 03/09/2026
The largest optogenetic protein campaign to date is powered by this automated patch clamp machine. Since we first turned it on in 2025, it has tested more than 2500 opsins.
010
Science Corp @science.xyz · 27/08/2026
To ensure our Science Biohybrid cells have the right genetic edits, we sort one cell from a million.
000
Science Corp @science.xyz · 21/08/2026
Max Hodak on No Priors discusses what comes next for Science, from our PRIMA retinal implant to biohybrid neural interfaces and the future of neural engineering. Thank you Sarah Guo for the great conversation.
120
Science Corp @science.xyz · 19/08/2026
We're designing implants to live inside the body for decades. Accelerated lifetime testing compresses years of testing into weeks; it validates that our devices can survive in vivo conditions long term.
110
Science Corp @science.xyz · 14/08/2026
„Unser Ziel ist es, Menschen verlorene körperliche Fähigkeiten zurückzugeben,“ sagte unser Chief Strategy Officer Darius Shahida. PRIMA kann Menschen, die ihr zentrales Sehvermögen aufgrund einer geografischen Atrophie verloren haben, wieder zu einem zentralen Sehvermögen verhelfen.
110
Science Corp @science.xyz · 12/08/2026
Everything about this room exists to protect the flexible substrate at the heart of our Biohybrid neural probes.
031
Science Corp @science.xyz · 04/08/2026
Every wafer that leaves Science Foundry must pass our engineers' inspection.
131
Science Corp @science.xyz · 27/07/2026
PRIMA received its CE mark, authorizing commercial use across Europe. Frank Brodie, Science's Medical Director for Vision and PRIMA, shares what this milestone means after a career treating geographic atrophy patients who can now benefit from PRIMA for the first time.
030
Science Corp @science.xyz · 22/07/2026
Die CE Kennzeichnung läutet die Europa- Markteinführung von PRIMA ein, der ersten und einzigen Therapie, die das funktionelle zentrale Sehvermögen von Patienten mit geografischer Atrophie, die durch trockene altersbedingte Makuladegeneration verursacht wird, wiederherstellen kann.
130
Science Corp @science.xyz · 22/07/2026
Today marks the European launch of PRIMA, the first and only treatment to be commercially available that restores functional central vision to patients with geographic atrophy caused by dry age-related macular degeneration, a leading cause of blindness.
1152
Science Corp @science.xyz · 16/07/2026
New 36-month clinical data for our PRIMA retinal implant will be presented for the first time at the 26th EURETINA Congress in Vienna, October 1-4 by Mahi Muqit, MD, co-author of the New England Journal of Medicine peer-reviewed original paper on the PRIMA.
110
Science Corp @science.xyz · 09/07/2026
Watch metal ions play atomic-scale billiards. That pink glow is a cloud of metal atoms bouncing off gas molecules as they deposit on a wafer.
120
Science Corp @science.xyz · 08/07/2026
In a San Francisco Chronicle front page story about the PRIMA retinal implant, our Medical Director for Vision Dr. Frank Brodie discusses how, in clinical trials, it helped restore meaningful vision to people living with geographic atrophy due to age-related macular degeneration.
140
Science Corp @science.xyz · 01/07/2026
Our Chief Scientific Officer and co-founder Alan Mardinly spoke at Frontiers of Neuro during Deep Tech Week in San Francisco to discuss Science’s work on PRIMA and Biohybrid.
020
Science Corp @science.xyz · 30/06/2026
The blade spins at 30,000 RPM through a wafer of exploratory biohybrid neural probes. They survive only if the water moves faster than the heat.
120
Science Corp @science.xyz · 23/06/2026
Frank Brodie, MD, Science's Medical Director for Vision and PRIMA, was honored with the Ascent to Excellence Award at the annual CTS Retina Meeting, which brings together retina specialists and industry partners to discuss advances in clinical research.
010
Science Corp @science.xyz · 18/06/2026
Watch a neural recording system small enough to fit in your pocket get built.
120
Science Corp @science.xyz · 12/06/2026
Science CEO Max Hodak joined @semafor.com Tech Editor Reed Albergotti on stage at First Principles for a wide-ranging conversation on longevity, Science's PRIMA retinal prosthesis and Vessel organ perfusion programs, and the philosophy of identity and BCI.
120
Science Corp @science.xyz · 11/06/2026
Science CEO Max Hodak spoke at TECH by Handelsblatt about the PRIMA implant for blindness caused by AMD/GA – and the landmark clinical trial published in The NEJM. Germany has been a partner in this work from the beginning and we expect it to be the first market where PRIMA is available at scale.
110
Science Corp @science.xyz · 08/06/2026
What does it take to build glasses that follow your eye movements? Watch our team integrate eye-tracking cameras into the next-generation PRIMA Glasses so patients can look around naturally.
120
Science Corp @science.xyz · 27/05/2026
Our team working on the next-generation PRIMA Glasses is focused on creating the best patient experience. How? By leveraging the “smartphone dividend.” Watch.
110
Science Corp @science.xyz · 20/05/2026
At Science, our cell engineers create neurons from stem cells. See what it looks like.
121
Science Corp @science.xyz · 13/05/2026
Construction is underway at our updated Science Foundry facility in Durham, NC for the manufacture of next-generation BCI devices.
110
Science Corp @science.xyz · 08/05/2026
Prof. Boris Stanzel (Eye Clinic Sulzbach, Knappschaft Hospital Saar & Department of Ophthalmology, University of Bonn) presenting at ARVO 2026 (Association for Research in Vision and Ophthalmology) delivered one of ten PRIMA presentations.
051
Science Corp @science.xyz · 07/05/2026
ARVO brings together the world's leading vision researchers and clinicians each year. This week, PRIMA by Science was featured in ten presentations across clinical outcomes, device training, surgical technique, and imaging.
120
Science Corp @science.xyz · 05/05/2026
What does it take to engineer a smaller, lighter, and more ergonomic PRIMA? Watch Episode 1: Our team tackles the next generation PRIMA Glasses.
120
Science Corp @science.xyz · 04/05/2026
Congratulations to José-Alain Sahel, MD, co-senior author of the PRIMA clinical trial, on receiving the 2026 Proctor Medal from the Association for Research in Vision and Ophthalmology, one of the highest honors in vision research.
020
Science Corp @science.xyz · 30/04/2026
New clinical and preclinical data on PRIMA by Science will be presented at ARVO 2026 in Denver this weekend across ten sessions: May 5: Palanker, Bittner, Hornig, Brodie, Stanzel May 6: Corazzol, Sahel, Ly May 7: Olmos De Koo, Trinh Lee
010
Science Corp @science.xyz · 29/04/2026
Teams from five universities used the Science Ecosystem to recreate the BCI loop in a single weekend. Watch what happens:
020
Science Corp @science.xyz · 17/04/2026
Come see a special preview of the next-generation PRIMA glasses at the Potsdam Meeting from April 17–18. The new glasses are updated for functionality, including integrated processing and eye tracking. Stop by our booth to connect with our team and learn more about the PRIMA system for GA/AMD.
121